Sponsor Pipeline

Joincare Pharmaceutical Group Industry Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07357051 Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301… Respiratory Viral Infection Recruiting
NCT07330310 A Phase 3 Trial of JKN2401 Injection in COPD Chronic Obstructive Pulmonary Disease (COPD) Not Yet Recruiting
Phase 2
NCT07351734 A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD COPD (Chronic Obstructive Pulmonary Disease) Recruiting
NCT07440524 A Phase 2 Trial of JKN24011 in COPD COPD (Chronic Obstructive Pulmonary Disease) Active, Not Recruiting
Phase 1
NCT07207291 Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese… Bacterial Infections Recruiting
Disease Areas
Get alerts when Joincare Pharmaceutical Group Industry Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free